Keros Therapeutics Stock (NASDAQ: KROS) stock price, news, charts, stock research, profile.
Open | $51.12 |
Close | - |
Volume / Avg. | 94.60K / 345.19K |
Day Range | 50.09 - 52.11 |
52 Wk Range | 27.02 - 73.00 |
Market Cap | $1.88B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 60 |
Short Interest | 10.07% |
Days to Cover | 4.61 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Keros Therapeutics (NASDAQ:KROS) through any online brokerage.
Other companies in Keros Therapeutics’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), Protagonist Therapeutics (NASDAQ:PTGX), Kiniksa Pharmaceuticals (NASDAQ:KNSA), Bicycle Therapeutics (NASDAQ:BCYC) and Nurix Therapeutics (NASDAQ:NRIX).
There is no analysis for Keros Therapeutics.
Keros Therapeutics has a consensus price target of $90.38.
The stock price for Keros Therapeutics (NASDAQ: KROS) is $50.445 last updated Today at July 17, 2024 at 11:59 AM EDT.
There are no upcoming dividends for Keros Therapeutics.
Keros Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Keros Therapeutics.
Keros Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.